Renal stem cell reprogramming: Prospects in regenerative medicine

doi:10.4252/wjsc.v6.i4.458

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7549)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

458

WORD

223

HTML

4168

Figures (1-2)

269

Sum=5118

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1115

Download

1316

Sum=2431

Sep 26, 2014 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Sep 26, 2014; 6(4): 458-466
Published online Sep 26, 2014. doi: 10.4252/wjsc.v6.i4.458

Renal stem cell reprogramming: Prospects in regenerative medicine

Elvin E Morales, Rebecca A Wingert

Elvin E Morales, Rebecca A Wingert, Department of Biological Sciences and Center for Zebrafish Research, University of Notre Dame, Notre Dame, IN 46556, United States

Author contributions: Morales EE and Wingert RA both designed the content of the manuscript, drafted and revised the manuscript, and approved the final version for publication.

Supported by National Institutes of Health, No. DP2 OD008470, R01 DK100237; Start-up funds from the University of Notre Dame and College of Science; and a generous donation for stem cell research to the University of Notre Dame by Elizabeth and Michael Gallagher on behalf of the Gallagher family

Correspondence to: Rebecca A Wingert, PhD, Department of Biological Sciences and Center for Zebrafish Research, University of Notre Dame, 100 Galvin Life Sciences, Notre Dame, IN 46556, United States. rwingert@nd.edu

Telephone: +1-574-6310907 Fax: +1-574-6317413

Received: July 26, 2014
Revised: August 21, 2014
Accepted: August 30, 2014
Published online: September 26, 2014
Processing time: 61 Days and 9.3 Hours

Core Tip

Core tip: The identification of regenerative therapies to treat kidney disease is an exciting but challenging area of ongoing scientific investigation. Cellular reprogramming may provide a tractable means to replace damaged renal tissue, and current researchers have pursued a number of innovative ways to produce renal cell types. Here we explore the issues confronting several reprogramming technologies, recent advances in reprogramming renal cells, and discuss areas of future scrutiny that are needed to help develop cell-based therapies for various kidney disease conditions.